With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX.
Analysts at Bell Potter have recently named a select group of ASX shares they believe represent the very best opportunities on the market right now.
Here are three of Bell Potter's top-rated shares to buy now — and why they're backed to outperform.
James Hardie Industries plc (ASX: JHX)
The first ASX share that could be a best buy according to Bell Potter is James Hardie. It is the dominant player in fibre cement and internal lining solutions — and it is particularly well positioned in the U.S. residential market, where a structural shift is taking place away from timber and vinyl towards more durable and lower-maintenance options like fibre cement.
Bell Potter believes this macro trend is set to continue, giving James Hardie a powerful multi-year tailwind. Following a recent pullback in the share price, the broker sees a compelling buying opportunity. It commented:
In our view, JHX is poised for continued earnings expansion, driven by the structural shift towards fibre cement in the US. Households in the US continue to shift to fibre cement cladding from vinyl/timber, providing a multi-year runway for JHX's revenue and profit growth.
Telix Pharmaceuticals Ltd (ASX: TLX)
Telix is quickly establishing itself as one of the most promising ASX healthcare shares. The company has successfully commercialised Illuccix, a prostate cancer imaging agent, and has multiple product launches and clinical trial readouts expected over the next two years.
The broker sees Telix as uniquely positioned in the growing field of radiopharmaceuticals, where demand for precision diagnostics and targeted therapies is accelerating. It also points to Telix's strong earnings growth outlook and attractive valuation. It said:
Valuations are attractive, with 12MF P/E now at 41x, supported by a 2yr EPS CAGR of 44%.
WiseTech Global Ltd (ASX: WTC)
A third ASX share that could be a best buy is WiseTech Global. It is the dominant force in global freight forwarding software. Its flagship CargoWise platform is mission-critical for some of the world's biggest logistics players, offering integration, automation, and efficiency at scale.
Bell Potter sees ongoing growth through both organic expansion and strategic acquisitions, with the company set to benefit from global supply chain digitisation and further product rollouts. The broker said:
WTC is a growth story with strategic acquisitions representing upside potential enabling WTC to benefit from large-scale global rollouts and consolidation within the logistics sector.
The post 3 of the very best ASX shares to buy now appeared first on The Motley Fool Australia.
Motley Fool contributor James Mickleboro has positions in WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2025